These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 9630231)

  • 21. Regulation of RAG transposition.
    Matthews AG; Oettinger MA
    Adv Exp Med Biol; 2009; 650():16-31. PubMed ID: 19731798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.
    Williams CJ; Grandal I; Vesprini DJ; Wojtyra U; Danska JS; Guidos CJ
    Mol Cell Biol; 2001 Jan; 21(2):400-13. PubMed ID: 11134329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HyperIgE in hypomorphic recombination-activating gene defects.
    Castiello MC; Brandas C; Capo V; Villa A
    Curr Opin Immunol; 2023 Feb; 80():102279. PubMed ID: 36529093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal diagnosis of RAG-deficient Omenn syndrome.
    Villa A; Bozzi F; Sobacchi C; Strina D; Fasth A; Pasic S; Notarangelo LD; Vezzoni P
    Prenat Diagn; 2000 Jan; 20(1):56-9. PubMed ID: 10701853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterification steps of V(D)J recombination.
    Swanson PC
    Mol Cell Biol; 2001 Jan; 21(2):449-58. PubMed ID: 11134333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.
    Oettinger MA; Schatz DG; Gorka C; Baltimore D
    Science; 1990 Jun; 248(4962):1517-23. PubMed ID: 2360047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of mutations from SCID and Omenn syndrome patients reveals the central role of the Rag2 PHD domain in regulating V(D)J recombination.
    Couëdel C; Roman C; Jones A; Vezzoni P; Villa A; Cortes P
    J Clin Invest; 2010 Apr; 120(4):1337-44. PubMed ID: 20234091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel missense RAG-1 mutation results in T-B-NK+ SCID in Athabascan-speaking Dine Indians from the Canadian Northwest Territories.
    Xiao Z; Yannone SM; Dunn E; Cowan MJ
    Eur J Hum Genet; 2009 Feb; 17(2):205-12. PubMed ID: 18701881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. V(D)J recombination: RAG proteins, repair factors, and regulation.
    Gellert M
    Annu Rev Biochem; 2002; 71():101-32. PubMed ID: 12045092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches.
    Bosticardo M; Pala F; Notarangelo LD
    Eur J Immunol; 2021 May; 51(5):1028-1038. PubMed ID: 33682138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human RAG mutations: biochemistry and clinical implications.
    Notarangelo LD; Kim MS; Walter JE; Lee YN
    Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathymic restriction and peripheral expansion of the T-cell repertoire in Omenn syndrome.
    Signorini S; Imberti L; Pirovano S; Villa A; Facchetti F; Ungari M; Bozzi F; Albertini A; Ugazio AG; Vezzoni P; Notarangelo LD
    Blood; 1999 Nov; 94(10):3468-78. PubMed ID: 10552957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination.
    Li W; Chang FC; Desiderio S
    Mol Cell Biol; 2001 Jun; 21(12):3935-46. PubMed ID: 11359901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
    Niehues T; Perez-Becker R; Schuetz C
    Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional clustering of human RAG2 gene mutations in severe combined immune deficiency.
    Corneo B; Moshous D; Callebaut I; de Chasseval R; Fischer A; de Villartay JP
    J Biol Chem; 2000 Apr; 275(17):12672-5. PubMed ID: 10777560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A RAG-1/RAG-2 tetramer supports 12/23-regulated synapsis, cleavage, and transposition of V(D)J recombination signals.
    Swanson PC
    Mol Cell Biol; 2002 Nov; 22(22):7790-801. PubMed ID: 12391148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The origins of V(D)J recombination.
    Lewis SM; Wu GE
    Cell; 1997 Jan; 88(2):159-62. PubMed ID: 9008155
    [No Abstract]   [Full Text] [Related]  

  • 38. Making V(D)J rearrangement visible: quantification of recombination efficiency in real time at the single cell level.
    Zheng X; Schwarz K
    J Immunol Methods; 2006 Aug; 315(1-2):133-43. PubMed ID: 16935293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal and spatial regulation of V(D)J recombination: interactions of extrinsic factors with the RAG complex.
    Liu Y; Zhang L; Desiderio S
    Adv Exp Med Biol; 2009; 650():157-65. PubMed ID: 19731809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
    Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.